当前位置:首页 - 行情中心 - 智飞生物(300122) - 财务分析

智飞生物

(300122)

  

流通市值:421.04亿  总市值:712.63亿
流通股本:14.14亿   总股本:23.94亿

智飞生物(300122)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润21.51亿元,每股收益0.90元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益3144164.18万元,未分配利润2809370.72万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产5370957.46万元,负债2226793.28万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入22,786,306,742.4318,258,441,511.2511,395,682,504.7152,917,767,029.2
营业总成本19,685,884,775.9915,281,723,020.219,323,352,619.2643,094,356,363.43
营业利润2,484,710,924.742,579,122,973.71,736,662,374.469,373,439,535.35
利润总额2,477,954,662.482,572,704,157.621,733,765,069.359,342,293,287.68
净利润2,150,622,937.942,234,319,364.611,457,744,248.178,069,868,204.15
其他综合收益----
综合收益总额2,150,622,937.942,234,319,364.611,457,744,248.178,069,868,204.15
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计45,458,060,346.5546,812,204,603.2445,731,274,065.942,514,016,731.06
非流动资产合计8,251,514,241.98,032,922,341.937,837,526,782.977,718,173,583.29
资产总计53,709,574,588.4554,845,126,945.1753,568,800,848.8750,232,190,314.35
流动负债合计21,649,036,529.0322,652,517,364.1720,211,954,471.5318,086,487,010.4
非流动负债合计618,896,277.89667,271,372.8693,051,487.98639,622,490.63
负债合计22,267,932,806.9223,319,788,736.9720,905,005,959.5118,726,109,501.03
归属于母公司股东权益合计31,441,641,781.5331,525,338,208.232,663,794,889.3631,506,080,813.32
股东权益合计31,441,641,781.5331,525,338,208.232,663,794,889.3631,506,080,813.32
负债和股东权益合计53,709,574,588.4554,845,126,945.1753,568,800,848.8750,232,190,314.35
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计28,515,112,725.119,964,897,857.098,387,064,252.2848,064,340,214.75
经营活动现金流出小计31,580,081,449.8320,272,219,698.9812,660,740,852.0339,067,970,233.62
经营活动产生的现金流量净额-3,064,968,724.73-307,321,841.89-4,273,676,599.758,996,369,981.13
投资活动现金流入小计4,655,142.174,641,142.1723,000168,073,400.86
投资活动现金流出小计700,478,076.61427,713,652.42236,232,912.391,144,672,122.45
投资活动产生的现金流量净额-695,822,934.44-423,072,510.25-236,209,912.39-976,598,721.59
筹资活动现金流入小计10,265,312,326.465,898,318,287.24,097,486,1526,347,985,763.87
筹资活动现金流出小计9,580,673,016.85,922,028,910.862,956,497,313.3210,641,852,590.69
筹资活动产生的现金流量净额684,639,309.66-23,710,623.661,140,988,838.68-4,293,866,826.82
汇率变动对现金及现金等价物的影响-801,413.27534,612.59161,585.67-2,303,049.15
现金及现金等价物净增加额-3,076,953,762.78-753,570,363.21-3,368,736,087.793,723,601,383.57
期末现金及现金等价物余额3,262,336,472.135,585,719,871.72,970,554,147.126,339,290,234.91
最新报告期:2024-10-28
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
中信建投刘若飞,贺菊颖1.271.752.332024-10-28
海通证券余文心2.913.424.572024-09-12
国联证券郑薇2.302.503.002024-09-05
中信建投刘若飞,贺菊颖2.432.833.202024-09-03
TOP↑